Comparative Risk of Ischemic Stroke Among Users of Clopidogrel Together With Individual Proton Pump Inhibitors | Zendy

Charles E. Leonard | Zendy; Warren B. Bilker | Zendy; Colleen Brensinger | Zendy; David A. Flockhart | Zendy; Cristin P Freeman | Zendy; Scott E. Kasner | Zendy; Stephen E. Kimmel | Zendy; Sean Hennessy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparative Risk of Ischemic Stroke Among Users of Clopidogrel Together With Individual Proton Pump Inhibitors

Author(s) -

Charles E. Leonard,

Warren B. Bilker,

Colleen Brensinger,

David A. Flockhart,

Cristin P Freeman,

Scott E. Kasner,

Stephen E. Kimmel,

Sean Hennessy

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.114.006866

Subject(s) - clopidogrel , medicine , esomeprazole , lansoprazole , pantoprazole , stroke (engine) , omeprazole , aspirin , rabeprazole , proton pump inhibitor , concomitant , mechanical engineering , engineering

There is controversy and little information about whether individual proton pump inhibitors (PPIs) differentially alter the effectiveness of clopidogrel in reducing ischemic stroke risk. We, therefore, aimed to elucidate the risk of ischemic stroke among concomitant users of clopidogrel and individual PPIs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research